tiprankstipranks
Advertisement
Advertisement

PHAR Stock Latest News

Pharming Group Sets May 28, 2026 AGM With Key Governance and Capital Measures on Agenda
Company AnnouncementsPharming Group Sets May 28, 2026 AGM With Key Governance and Capital Measures on Agenda
5d ago
6K
PHAR
Pharming initiated with a Buy at Canaccord on growth potential
PremiumThe Fly
Pharming initiated with a Buy at Canaccord on growth potential
11d ago
PHAR
Pharming initiated with a Buy at Canaccord
PremiumThe Fly
Pharming initiated with a Buy at Canaccord
11d ago
PHAR
Pharming Group Files 2025 Annual Report and Form 20-F
PremiumCompany Announcements
Pharming Group Files 2025 Annual Report and Form 20-F
19d ago
6K
PHAR
Pharming Group Wins Positive EMA Panel Backing for Joenja in Rare APDS
PremiumCompany Announcements
Pharming Group Wins Positive EMA Panel Backing for Joenja in Rare APDS
25d ago
6K
PHAR
Pharming announces approval of Joenja in Japan for patients aged 4 years and old
PremiumThe FlyPharming announces approval of Joenja in Japan for patients aged 4 years and old
28d ago
PHAR
Pharming Group Wins Landmark Japan Approval for Joenja in Pediatric and Adult APDS
Premium
Company Announcements
Pharming Group Wins Landmark Japan Approval for Joenja in Pediatric and Adult APDS
28d ago
6K
PHAR
Pharming price target lowered to $41 from $42 at Oppenheimer
Premium
The Fly
Pharming price target lowered to $41 from $42 at Oppenheimer
1M ago
PHAR
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
PremiumRatings
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
1M ago
PHAR
Pharming Group Posts Strong 2025 Growth, Turns Profitable and Lifts 2026 Outlook
PremiumCompany Announcements
Pharming Group Posts Strong 2025 Growth, Turns Profitable and Lifts 2026 Outlook
1M ago
6K
PHAR
PHAR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PHAR Upcoming Earnings Report: What to Expect?
1M ago
PHAR
Pharming Group Sets 2026 Guidance and Showcases Rare Disease Pipeline at Investor Day
PremiumCompany Announcements
Pharming Group Sets 2026 Guidance and Showcases Rare Disease Pipeline at Investor Day
3M ago
6K
PHAR
Morning Movers: Disney dips following fourth quarter earnings
PremiumThe FlyMorning Movers: Disney dips following fourth quarter earnings
3M ago
DIS
DVN
Pharming to host virtual investor day
Premium
The Fly
Pharming to host virtual investor day
3M ago
PHAR
Pharming receives CRL from U.S. FDA for sNDA for Joenja
Premium
The Fly
Pharming receives CRL from U.S. FDA for sNDA for Joenja
3M ago
PHAR
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
PremiumMarket News
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
3M ago
AQST
IRON
Pharming Group Beats 2025 Revenue Guidance and Sets February Investor Day
PremiumCompany Announcements
Pharming Group Beats 2025 Revenue Guidance and Sets February Investor Day
3M ago
6K
PHAR
Pharming price target raised to $42 from $41 at Oppenheimer
PremiumThe Fly
Pharming price target raised to $42 from $41 at Oppenheimer
5M ago
PHAR
Pharming Group Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Pharming Group Reports Strong Q3 2025 Growth
5M ago
PHAR
Pharming Group Reports Strong Q3 2025 Financial Growth and Strategic Updates
PremiumCompany AnnouncementsPharming Group Reports Strong Q3 2025 Financial Growth and Strategic Updates
6M ago
6K
PHAR
Pharming Group to Present New Data at ACAAI 2025
Premium
Company Announcements
Pharming Group to Present New Data at ACAAI 2025
6M ago
6K
PHAR
Pharming Group Announces Restructuring to Cut Costs and Boost Growth
Premium
Company Announcements
Pharming Group Announces Restructuring to Cut Costs and Boost Growth
7M ago
6K
PHAR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >